Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul;36(5):935-938.
doi: 10.1007/s10103-020-03206-9. Epub 2020 Nov 25.

Photobiomodulation therapy as a high potential treatment modality for COVID-19

Sepideh Soheilifar  1 , Homa Fathi  2 , Navid Naghdi  3
Affiliations
Review

Photobiomodulation therapy as a high potential treatment modality for COVID-19

Sepideh Soheilifar et al. Lasers Med Sci. 2021 Jul.

Abstract

COVID-19 is now a worldwide concern, causing an unprecedented pandemic. The infected cases show different symptoms based on the severity of the disease. In asymptomatic and non-severe symptomatic cases, the host immune system can successfully eliminate the virus and its effects. In severe cases, however, immune system impairment causes cytokine release syndrome which eventually leads to acute respiratory distress syndrome (ARDS). In recent years, photobiomodulation (PBM) has shown promising results in reducing acute pulmonary inflammation. Considering the high potential impact of PBM on immune responses, we hypothesized that using PBM could be an effective treatment modality for ARDS management in COVID-19 patients.

Keywords: COVID-19; Coronavirus; Inflammation; Low-level light therapy; Photobiomodulation; Respiratory distress syndrome, adult.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

References

    1. WHO (2020) No Title. In: Coronavirus Dis. 2019 Situat. Rep. – 51. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... Accessed 11 Mar 2020
    1. Phan MVT, Ngo Tri T, Hong Anh P, et al (2018) Identification and characterization of Coronaviridae genomes from Vietnamese bats and rats based on conserved protein domains. Virus Evol 4:vey035 - PMC - PubMed
    1. Kumar S, Maurya VK, Prasad AK et al (2020) Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). VirusDisease 1–9 - PMC - PubMed
    1. Ortiz-Prado E, Simbaña-Rivera K, Gómez-Barreno L, et al. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn Microbiol Infect Dis. 2020;98:115094. doi: 10.1016/j.diagmicrobio.2020.115094. - DOI - PMC - PubMed
    1. Shi Y, Wang Y, Shao C et al (2020) COVID-19 infection: the perspectives on immune responses - PMC - PubMed

Substances